PRAXIS PRECISION MEDICINES I (PRAX) Stock Analyst Ratings
USA - NASDAQ:PRAX - US74006W2070 - Common Stock
198.76 USD
-2.24 (-1.11%)
198.56 USD
-0.2 (-0.1%)
ChartMill assigns a Buy % Consensus number of 82% to PRAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 258.64. This target is 30.13% above the current price.
PRAX was analyzed by 20 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about PRAX.
In the previous month the buy percentage consensus was at a similar level.
PRAX was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-20 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-10-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-10-17 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-17 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-10-17 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-16 | Needham | Maintains | Buy -> Buy |
| 2025-10-16 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-18 | Jones Trading | Initiate | Buy |
| 2025-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-29 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-06-12 | Needham | Reiterate | Buy -> Buy |
| 2025-05-07 | Chardan Capital | Initiate | Buy |
| 2025-05-05 | Needham | Reiterate | Buy -> Buy |
| 2025-05-05 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-05-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-03-03 | Needham | Maintains | Buy -> Buy |
| 2025-03-03 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-03 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-11 | Deutsche Bank | Initiate | Buy |
| 2025-02-10 | Needham | Reiterate | Buy -> Buy |
| 2025-01-21 | Truist Securities | Maintains | Buy -> Buy |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | Oppenheimer | Maintains | Outperform -> Outperform |
PRAXIS PRECISION MEDICINES I / PRAX FAQ
What is the price target for PRAX stock?
20 analysts have analysed PRAX and the average price target is 258.64 USD. This implies a price increase of 30.13% is expected in the next year compared to the current price of 198.76.
How do analysts rate PRAXIS PRECISION MEDICINES I (PRAX)?
The consensus rating for PRAXIS PRECISION MEDICINES I (PRAX) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed PRAXIS PRECISION MEDICINES I (PRAX)?
The number of analysts covering PRAXIS PRECISION MEDICINES I (PRAX) is 20.